{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:13:10Z","timestamp":1789827190499,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. NAFLD encompasses a spectrum of liver damage starting with liver steatosis and lipid disorders presented as the hallmark. Cannabinoid-2 receptor (CB2R) is the receptor of endocannabinoids mainly expressed in immune cells. Our preliminary study revealed the preventative role of CB2R in liver injury related to lipid metabolism. In this study, we aimed to explore the role of CB2R in NAFLD and the underlying mechanism related to microbial community. High-fat diet-induced NAFLD model was established in mice. We found that hepatic CB2R expression was significantly reduced in NAFLD mice and CB2R\n                    <jats:sup>\u2013\/\u2013<\/jats:sup>\n                    mice fed with normal chow. Interestingly, cohousing with or transplanted with\u00a0microbiota from WT mice, or treatment with an antibiotic cocktail ameliorated the NAFLD phenotype of CB2R\n                    <jats:sup>\u2013\/\u2013<\/jats:sup>\n                    mice. The gut dysbiosis in CB2R\n                    <jats:sup>\u2013\/\u2013<\/jats:sup>\n                    mice including increased Actinobacteriota and decreased Bacteroidota was similar to that of NAFLD patients and NAFLD mice. Microbial functional analysis and metabolomics profiling revealed obviously disturbed tryptophan metabolism in NAFLD patients and NAFLD mice, which were also seen in CB2R\n                    <jats:sup>\u2013\/\u2013<\/jats:sup>\n                    mice. Correlation network showed that the disordered tryptophan metabolites such as indolelactic acid (ILA) and xanthurenic acid in CB2R\n                    <jats:sup>-\/-<\/jats:sup>\n                    mice were mediated by gut dysbiosis and related to NAFLD severity indicators. In vitro and in vivo validation experiments showed that the enriched tryptophan metabolites ILA aggravated NAFLD phenotypes. These results demonstrate the involvement of CB2R in NAFLD, which is related to gut microbiota-mediated tryptophan metabolites. Our findings highlight CB2R and the associated microbes and tryptophan metabolites as promising targets for the treatment of NAFLD.\n                  <\/jats:p>","DOI":"10.1038\/s41401-025-01495-w","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T06:15:36Z","timestamp":1740032136000},"page":"1676-1691","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cannabinoid-2 receptor depletion promotes non-alcoholic fatty liver disease in mice via disturbing gut microbiota and tryptophan metabolism"],"prefix":"10.1038","volume":"46","author":[{"given":"Wei-ting","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-ya","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-fang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-bing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"1495_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby T, Gautier EL. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat Rev Immunol. 2022;22:429\u201343.","journal-title":"Nat Rev Immunol"},{"key":"1495_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","volume":"11","author":"T Hardy","year":"2016","unstructured":"Hardy T, Oakley F, Anstee QM, Day CP. Nonalcoholic fatty liver disease: pathogenesis and disease spectrum. Annu Rev Pathol. 2016;11:451\u201396.","journal-title":"Annu Rev Pathol"},{"key":"1495_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41575-018-0055-0","volume":"16","author":"MCS Wong","year":"2019","unstructured":"Wong MCS, Huang JLW, George J, Huang J, Leung C, Eslam M, et al. The changing epidemiology of liver diseases in the Asia-Pacific region. Nat Rev Gastroenterol Hepatol. 2019;16:57\u201373.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1495_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"1495_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","volume":"72","author":"JM Paik","year":"2020","unstructured":"Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD. Hepatology. 2020;72:1605\u201316.","journal-title":"Hepatology"},{"key":"1495_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.14218\/JCTH.2020.00014","volume":"8","author":"C Gadiparthi","year":"2020","unstructured":"Gadiparthi C, Spatz M, Greenberg S, Iqbal U, Kanna S, Satapathy SK, et al. NAFLD epidemiology, emerging pharmacotherapy, liver transplantation implications and the trends in the United States. J Clin Transl Hepatol. 2020;8:215\u201321.","journal-title":"J Clin Transl Hepatol"},{"key":"1495_CR7","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/hep.27686","volume":"61","author":"B Mukhopadhyay","year":"2015","unstructured":"Mukhopadhyay B, Schuebel K, Mukhopadhyay P, Cinar R, Godlewski G, Xiong K, et al. Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms. Hepatology. 2015;61:1615\u201326.","journal-title":"Hepatology"},{"key":"1495_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejim.2018.01.009","volume":"49","author":"J Tam","year":"2018","unstructured":"Tam J, Hinden L, Drori A, Udi S, Azar S, Baraghithy S. The therapeutic potential of targeting the peripheral endocannabinoid\/CB(1) receptor system. Eur J Intern Med. 2018;49:23\u20139.","journal-title":"Eur J Intern Med"},{"key":"1495_CR9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/hep.30364","volume":"69","author":"J Liu","year":"2019","unstructured":"Liu J, Godlewski G, Jourdan T, Liu Z, Cinar R, Xiong K, et al. Cannabinoid-1 receptor antagonism improves glycemic control and increases energy expenditure through sirtuin-1\/mechanistic target of rapamycin complex 2 and 5\u2019adenosine monophosphate-activated protein kinase signaling. Hepatology. 2019;69:1535\u201348.","journal-title":"Hepatology"},{"key":"1495_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fendo.2019.00311","volume":"10","author":"I Pepper","year":"2019","unstructured":"Pepper I, Vinik A, Lattanzio F, McPheat W, Dobrian A. Countering the modern metabolic disease rampage with ancestral endocannabinoid system alignment. Front Endocrinol (Lausanne). 2019;10:311.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1495_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202306176","volume":"62","author":"SAM Steinm\u00fcller","year":"2023","unstructured":"Steinm\u00fcller SAM, Fender J, Deventer MH, Tutov A, Lorenz K, Stove CP, et al. Visible-light photoswitchable benzimidazole azo-arenes as \u03b2-arrestin2-biased selective cannabinoid 2 receptor agonists. Angew Chem Int Ed Engl. 2023;62:e202306176.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1495_CR12","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s41401-022-01037-8","volume":"44","author":"SL Cai","year":"2023","unstructured":"Cai SL, Fan XG, Wu J, Wang Y, Hu XW, Pei SY, et al. CB2R agonist GW405833 alleviates acute liver failure in mice via inhibiting HIF-1\u03b1-mediated reprogramming of glycometabolism and macrophage proliferation. Acta Pharmacol Sin. 2023;44:1391\u2013403.","journal-title":"Acta Pharmacol Sin"},{"key":"1495_CR13","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71:1020\u201332.","journal-title":"Gut"},{"key":"1495_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","volume":"21","author":"CL Hsu","year":"2023","unstructured":"Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023;21:719\u201333.","journal-title":"Nat Rev Microbiol"},{"key":"1495_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79718-9","volume":"11","author":"N Lanthier","year":"2021","unstructured":"Lanthier N, Rodriguez J, Nachit M, Hiel S, Trefois P, Neyrinck AM, et al. Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients. Sci Rep. 2021;11:659.","journal-title":"Sci Rep."},{"key":"1495_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01709-5","volume":"11","author":"H Xu","year":"2023","unstructured":"Xu H, Fang F, Wu K, Song J, Li Y, Lu X, et al. Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia. Microbiome. 2023;11:262.","journal-title":"Microbiome"},{"key":"1495_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m A, Sayin SI, Marschall HU, B\u00e4ckhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24:41\u201350.","journal-title":"Cell Metab"},{"key":"1495_CR18","doi-asserted-by":"publisher","DOI":"10.1515\/biol-2022-0699","volume":"18","author":"Y Yao","year":"2023","unstructured":"Yao Y, Shen Y. Cross-talk between gut microbiota and liver steatosis: complications and therapeutic target. Open Life Sci. 2023;18:20220699.","journal-title":"Open Life Sci"},{"key":"1495_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","volume":"13","author":"ME Rinella","year":"2016","unstructured":"Rinella ME, Sanyal AJ. Management of NAFLD: a stage-based approach. Nat Rev Gastroenterol Hepatol. 2016;13:196\u2013205.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1495_CR20","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","volume":"142","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592\u2013609.","journal-title":"Gastroenterology"},{"key":"1495_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13839","volume":"7","author":"F Li","year":"2017","unstructured":"Li F, Hao X, Chen Y, Bai L, Gao X, Lian Z, et al. The microbiota maintain homeostasis of liver-resident \u03b3\u03b4T-17 cells in a lipid antigen\/CD1d-dependent manner. Nat Commun. 2017;7:13839.","journal-title":"Nat Commun"},{"key":"1495_CR22","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1016\/j.celrep.2019.05.042","volume":"27","author":"R Caruso","year":"2019","unstructured":"Caruso R, Ono M, Bunker ME, N\u00fa\u00f1ez G, Inohara N. Dynamic and asymmetric changes of the microbial communities after cohousing in laboratory mice. Cell Rep. 2019;27:3401\u201312.e3403.","journal-title":"Cell Rep."},{"key":"1495_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.lfs.2018.04.022","volume":"203","author":"X Chen","year":"2018","unstructured":"Chen X, Li L, Liu X, Luo R, Liao G, Li L, et al. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis. Life Sci. 2018;203:291\u2013304.","journal-title":"Life Sci"},{"key":"1495_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101634","volume":"36","author":"F Xu","year":"2020","unstructured":"Xu F, Guo M, Huang W, Feng L, Zhu J, Luo K, et al. Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH. Redox Biol. 2020;36:101634.","journal-title":"Redox Biol"},{"key":"1495_CR25","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.clnu.2019.05.020","volume":"39","author":"M Chen","year":"2020","unstructured":"Chen M, Hou P, Zhou M, Ren Q, Wang X, Huang L, et al. Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. Clin Nutr. 2020;39:1264\u201375.","journal-title":"Clin Nutr"},{"key":"1495_CR26","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1002\/hep.32066","volume":"74","author":"M Hu","year":"2021","unstructured":"Hu M, Zhang D, Xu H, Zhang Y, Shi H, Huang X, et al. Salidroside activates the AMP-activated protein kinase pathway to suppress nonalcoholic steatohepatitis in mice. Hepatology. 2021;74:3056\u201373.","journal-title":"Hepatology"},{"key":"1495_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nmeth.2276","volume":"10","author":"NA Bokulich","year":"2013","unstructured":"Bokulich NA, Subramanian S, Faith JJ, Gevers D, Gordon JI, Knight R, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods. 2013;10:57\u20139.","journal-title":"Nat Methods"},{"key":"1495_CR28","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/bioinformatics\/btu494","volume":"30","author":"DH Parks","year":"2014","unstructured":"Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014;30:3123\u20134.","journal-title":"Bioinformatics"},{"key":"1495_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6:1060\u201383.","journal-title":"Nat Protoc"},{"key":"1495_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith CA, Want EJ, O\u2019Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78:779\u201387.","journal-title":"Anal Chem"},{"key":"1495_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1021\/ac0713510","volume":"80","author":"S Wiklund","year":"2008","unstructured":"Wiklund S, Johansson E, Sj\u00f6str\u00f6m L, Mellerowicz EJ, Edlund U, Shockcor JP, et al. Visualization of GC\/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem. 2008;80:115\u201322.","journal-title":"Anal Chem"},{"key":"1495_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","volume":"18","author":"Y Filali-Mouncef","year":"2022","unstructured":"Filali-Mouncef Y, Hunter C, Roccio F, Zagkou S, Dupont N, Primard C, et al. The m\u00e9nage \u00e0 trois of autophagy, lipid droplets and liver disease. Autophagy. 2022;18:50\u201372.","journal-title":"Autophagy"},{"key":"1495_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41757-x","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang W, Tan J, Liu X, Guo W, Li M, Liu X, et al. Cytoplasmic Endonuclease G promotes nonalcoholic fatty liver disease via mTORC2-AKT-ACLY and endoplasmic reticulum stress. Nat Commun. 2023;14:6201.","journal-title":"Nat Commun"},{"key":"1495_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","volume":"20","author":"M Schoeler","year":"2019","unstructured":"Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019;20:461\u201372.","journal-title":"Rev Endocr Metab Disord"},{"key":"1495_CR35","doi-asserted-by":"crossref","unstructured":"Guo H, Chou WC, Lai Y, Liang K, Tam JW, Brickey WJ et al. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. Science. 2020;370:eaay9097.","DOI":"10.1126\/science.aay9097"},{"key":"1495_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154576","volume":"109","author":"X Huang","year":"2023","unstructured":"Huang X, Yuan Z, Liu X, Wang Z, Lu J, Wu L, et al. Integrative multi-omics unravels the amelioration effects of Zanthoxylum bungeanum Maxim. on non-alcoholic fatty liver disease. Phytomedicine. 2023;109:154576.","journal-title":"Phytomedicine"},{"key":"1495_CR37","doi-asserted-by":"crossref","unstructured":"Wei J, Zhao Y, Zhou C, Zhao Q, Zhong H, Zhu X et al. Dietary polysaccharide from enteromorpha clathrata attenuates obesity and increases the intestinal abundance of butyrate-producing bacterium, Eubacterium xylanophilum, in mice fed a high-fat diet. Polymers (Basel). 2021;13:3286.","DOI":"10.3390\/polym13193286"},{"key":"1495_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35861-1","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, Qi X, Li N, Kaifi JT, Chen S, Wheeler AA, et al. Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol. Nat Commun. 2023;14:228.","journal-title":"Nat Commun"},{"key":"1495_CR39","doi-asserted-by":"crossref","unstructured":"Varsha KK, Nagarkatti M, Nagarkatti P. Role of gut microbiota in cannabinoid-mediated suppression of inflammation. Adv Drug Alcohol Res. 2022;2:10550.","DOI":"10.3389\/adar.2022.10550"},{"key":"1495_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02729-6","volume":"20","author":"M McDew-White","year":"2023","unstructured":"McDew-White M, Lee E, Premadasa LS, Alvarez X, Okeoma CM, Mohan M. Cannabinoids modulate the microbiota-gut-brain axis in HIV\/SIV infection by reducing neuroinflammation and dysbiosis while concurrently elevating endocannabinoid and indole-3-propionate levels. J Neuroinflammation. 2023;20:62.","journal-title":"J Neuroinflammation"},{"key":"1495_CR41","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.chom.2023.03.020","volume":"31","author":"S Porcari","year":"2023","unstructured":"Porcari S, Benech N, Valles-Colomer M, Segata N, Gasbarrini A, Cammarota G, et al. Key determinants of success in fecal microbiota transplantation: from microbiome to clinic. Cell Host Microbe. 2023;31:712\u201333.","journal-title":"Cell Host Microbe"},{"key":"1495_CR42","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1038\/s41591-022-01913-0","volume":"28","author":"TSB Schmidt","year":"2022","unstructured":"Schmidt TSB, Li SS, Maistrenko OM, Akanni W, Coelho LP, Dolai S, et al. Drivers and determinants of strain dynamics following fecal microbiota transplantation. Nat Med. 2022;28:1902\u201312.","journal-title":"Nat Med"},{"key":"1495_CR43","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1038\/oby.2009.177","volume":"17","author":"S Karaliota","year":"2009","unstructured":"Karaliota S, Siafaka-Kapadai A, Gontinou C, Psarra K, Mavri-Vavayanni M. Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation. Obesity (Silver Spring). 2009;17:1830\u20138.","journal-title":"Obesity (Silver Spring)"},{"key":"1495_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108394","volume":"244","author":"C Chen","year":"2023","unstructured":"Chen C. Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases. Pharmacol Ther. 2023;244:108394.","journal-title":"Pharmacol Ther"},{"key":"1495_CR45","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1128\/aem.38.3.544-546.1979","volume":"38","author":"F Aragozzini","year":"1979","unstructured":"Aragozzini F, Ferrari A, Pacini N, Gualandris R. Indole-3-lactic acid as a tryptophan metabolite produced by Bifidobacterium spp. Appl Environ Microbiol. 1979;38:544\u20136.","journal-title":"Appl Environ Microbiol"},{"key":"1495_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6658674","volume":"2021","author":"G Shen","year":"2021","unstructured":"Shen G, Wu J, Ye BC, Qi N. Gut microbiota-derived metabolites in the development of diseases. Can J Infect Dis Med Microbiol. 2021;2021:6658674.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"1495_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1788899","volume":"12","author":"F Dong","year":"2020","unstructured":"Dong F, Hao F, Murray IA, Smith PB, Koo I, Tindall AM, et al. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes. 2020;12:1\u201324.","journal-title":"Gut Microbes"},{"key":"1495_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12866-020-02023-y","volume":"20","author":"AM Ehrlich","year":"2020","unstructured":"Ehrlich AM, Pacheco AR, Henrick BM, Taft D, Xu G, Huda MN, et al. Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiol. 2020;20:357.","journal-title":"BMC Microbiol"},{"key":"1495_CR49","doi-asserted-by":"crossref","unstructured":"Kim K, Kim H, Sung GY. Effects of indole-3-lactic acid, a metabolite of tryptophan, on IL-4 and IL-13-induced human skin-equivalent atopic dermatitis models. Int J Mol Sci. 2022;23:13520.","DOI":"10.3390\/ijms232113520"},{"key":"1495_CR50","doi-asserted-by":"publisher","first-page":"8793","DOI":"10.1080\/10408398.2021.1934813","volume":"62","author":"J Lin","year":"2022","unstructured":"Lin J, Sun-Waterhouse D, Cui C. The therapeutic potential of diet on immune-related diseases: based on the regulation on tryptophan metabolism. Crit Rev Food Sci Nutr. 2022;62:8793\u2013811.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1495_CR51","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.3748\/wjg.v23.i15.2771","volume":"23","author":"S Dong","year":"2017","unstructured":"Dong S, Zhan ZY, Cao HY, Wu C, Bian YQ, Li JY, et al. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease. World J Gastroenterol. 2017;23:2771\u201384.","journal-title":"World J Gastroenterol"},{"key":"1495_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00726-022-03123-x","volume":"54","author":"NP Hyland","year":"2022","unstructured":"Hyland NP, Cavanaugh CR, Hornby PJ. Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function. Amino Acids. 2022;54:57\u201370.","journal-title":"Amino Acids"},{"key":"1495_CR53","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus A, Cl\u00e9ment K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70:1174\u201382.","journal-title":"Gut"},{"key":"1495_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106346","volume":"26","author":"M Wang","year":"2023","unstructured":"Wang M, Li L, Qian J, Wang N, Bao J, Lu J, et al. Periodontitis salivary microbiota exacerbates nonalcoholic fatty liver disease in high-fat diet-induced obese mice. iScience. 2023;26:106346.","journal-title":"iScience"},{"key":"1495_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31126-5","volume":"13","author":"T Huang","year":"2022","unstructured":"Huang T, Song J, Gao J, Cheng J, Xie H, Zhang L, et al. Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR\/STAT3\/IL-6 signaling. Nat Commun. 2022;13:3489.","journal-title":"Nat Commun"},{"key":"1495_CR56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/oby.23065","volume":"29","author":"IY Rojas","year":"2021","unstructured":"Rojas IY, Moyer BJ, Ringelberg CS, Wilkins OM, Pooler DB, Ness DB, et al. Kynurenine-induced aryl hydrocarbon receptor signaling in mice causes body mass gain, liver steatosis, and hyperglycemia. Obesity (Silver Spring). 2021;29:337\u201349.","journal-title":"Obesity (Silver Spring)"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01495-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01495-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01495-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T07:04:02Z","timestamp":1747897442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01495-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1495"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01495-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}